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Abstract
Dietary folates have a key role to play in health, as deficiencies in the intake of these B vitamins have been implicated in a
wide variety of clinical conditions. The reason for this is folates function as single carbon donors in the synthesis of methio-
nine and nucleotides. Moreover, folates have a vital role to play in the epigenetics of mammalian cells by supplying methyl
groups for DNAmethylation reactions. Intriguingly, a growing body of experimental evidence suggests that DNAmethyla-
tion status could be a central modulator of the ageing process. This has important health implications because the methyla-
tion status of the human genome could be used to infer age-related disease risk. Thus, it is imperative we further our
understanding of the processes which underpin DNAmethylation and how these intersect with folate metabolism and age-
ing. The biochemical and molecular mechanisms, which underpin these processes, are complex. However, computational
modelling offers an ideal framework for handling this complexity. A number of computational models have been assembled
over the years, but to date, no model has represented the full scope of the interaction between the folate cycle and the
reactions, which governs the DNAmethylation cycle. In this review, we will discuss several of the models, which have been
developed to represent these systems. In addition, we will present a rationale for developing a combined model of folate
metabolism and the DNAmethylation cycle.
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Introduction
The term ‘folate’ (vitamin B9) is used to denote a group of com-
pounds that possess the same vitamin activity and includes
natural folates as well as the pharmacological compounds folic
acid and folinic acid [1]. The dietary importance of folate cannot
be overstated. This is emphasized by the wide range of clinical
disorders, which correlate with low folate status [2–4]. In add-
ition, polymorphisms in genes coding for folate-dependent
enzymes [5, 6] are associated with several cancers (cervical,
bronchial, colon and breast) [7–10], Alzheimer’s disease [11],
Down syndrome [12], unexplained recurrent early pregnancy
loss and pre-eclampsia [13]. These associations are unsurprising
when one considers that folates are involved in a ubiquitous
array of cellular processes. For instance, folates are involved in
the synthesis of nucleotides from purine precursors, participate
indirectly in the synthesis of transfer RNA and function as sin-
gle carbon donors during the re-methylation of homocysteine
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(Hcy) to methionine [14] (Figure 1). Folate-derived one-carbon
units also play a central role in DNA methylation [15, 16]. This
epigenetic process involves methyl groups covalently bonding
to CpG dinucleotides to establish tissue-specific methylation
patterns. A CpG dinucleotide consists of a deoxycytidine fol-
lowed by a deoxyguanidine, with the ‘p’ indicating the phos-
phate group between these nucleotides. Covalent bonding of
methyl groups occurs at the carbon-5 position of a deoxy-
cytidine to create a methylated CpG dyad [11, 12]. Dynamic
changes to methylation patterns are an important gestational
phenomenon, which regulate gene expression during embry-
onic development [17]. However, during adult life, alterations to
DNA methylation patterns can have significant implications for
the onset of disease [18, 19]. Specifically, advancing age is often
accompanied by global hypomethylation [20–23] in conjunction
with site-specific hypermethylation at the promoter region of a
variety of genes [24–27]. Hypermethylation involves CpG islands
(500–2000 bp) within the promoter becoming excessively
methylated [28, 29], and often occurs with concomitant tran-
scriptional silencing [30, 31]. Gene promoter hypermethylation
is a feature of certain diseases, the most notable being cancer
[25]. For instance, Wang et al. (2016) [32] recently found that
DNAmethylation changes during ageing were closely correlated
to the occurrence of cancer. In addition to cancer, aberrant DNA
methylation has an emerging role to play in many age-related
diseases, including cardiovascular disease (CVD) [33],
Alzheimer’s disease [34] and osteoporosis/osteoarthritis [35].
Such findings consolidate the growing view that DNA methyla-
tion status and health span are inexorably entwined. Moreover,
it has also been revealed that investigating changes to the
methylation profile of the genome could help develop our
understanding of ageing. This assertion is supported by the re-
cent bioinformatics work of Horvath (2013) [36] who used pub-
licly available methylation data sets to identify an ‘epigenetic
clock’ underpinned by methylation changes in 353 CpGs.
Intriguingly, Horvarth postulates that ‘DNA methylation age’
measures the cumulative effect of an epigenetic maintenance
system. This finding indicates that a deeper mechanistic under-
standing of DNA methylation preservation could be pivotal to
improving our overall understanding of ageing and health span.
To extend our understanding of DNA methylation and its bi-
directional relationship with ageing, it is imperative we con-
sider how subtle alterations to folate-mediated one carbon
metabolism (FOCM) impact the regulatory processes that govern
DNA methylation. Specifically, it is necessary to explore how
such perturbations affect gene promoters, which are susceptible
to hypermethylation. In addition, it is vital we consider how
other factors associated with ageing impact this relationship.
However, this is not a straightforward task, as both FOCM and
the DNA methylation cycle are complex processes, which are
underpinned by a large number of biochemical and molecular
reactions (Figure 1). Many of these reactions are non-linear in
nature and are influenced by a variety of other B vitamins/nutri-
ents and enzymatic cofactors [37]. Ageing adds a further degree
of complexity by altering the dynamics of the reactions. For
example, age-dependent decreases in the expression levels/
activity of human methionine synthase (MS) and methylenete-
trahydrofolate reductase (MTHFR) have been observed [38, 39].
Both enzymes are recognized as key regulators of FOCM, and ex-
pression/activity changes potentially affect their reaction kin-
etics. Similarly, the activity of human DNA methyltransferase 1
(Dnmt 1), a key enzyme involved in the addition of methyl
groups to cytosine residues, has also been observed to decrease
with age [40]. Moreover, ageing also affects the availability of
cofactors such as vitamin B12 [41], which is central to FOCM,
while oxidative stress, which is generally regarded as a key con-
tributor to ageing, has been observed to effect both DNA methy-
lation and FOCM [42, 43]. Furthermore, it is not uncommon that
older people have diminished folate status as a result of a low
dietary intake of the vitamin [44]. Thus, it is necessary to con-
sider an array of factors when investigating the maintenance of
DNA methylation. Fortunately, there is a growing appreciation
that complex biological process can be studied in a holistic
manner by adopting a systems biology approach [45].
Computational modelling resides at the centre of this paradigm
shift, as it provides a framework for representing and exploring
the dynamics of complex systems [46–50]. In this review, we
discuss the role computational modelling has played in de-
veloping our understanding of FOCM and DNA methylation. In
addition, we propose coupling FOCM and the DNA methylation
cycle into one computational model, which could be used to fur-
ther explore the dynamics of their relationship.
Folate metabolism and the DNA
methylation cycle
FOCM is fundamentally important to DNA methylation. Various
folates are the cofactors for the de novo synthesis of methyl
groups from more oxidized one-carbon units, and the methyl
groups on 5-methyltetrahydrofolate (5-MTFHF) are used to
re-methylate Hcy to methionine and to regenerate tetrahydro-
folate, the metabolically active form of folate. Methionine is a
precursor of S-adenosylmethionine (SAM), which has a predom-
inant role to play in the majority of biochemical methyl
donation events, including that of DNA methylation. Post-repli-
cation, Dnmt1 uses SAM as a substrate to transfer methyl
groups to the DNA molecule [51]; this produces S-adenosylho-
mocysteine (SAH). SAH is then converted to Hcy, permitting the
continuation of the methylation cycle [52, 53] (Figure 1). In con-
junction with Dnmt1, DNA methylation patterns are dynamic-
ally regulated by several other enzymes (Figure 1). As Dnmt1
preferentially acts on hemimethylated DNA and is potentially
unable to methylate neo-synthesized DNA strands, this enzyme
is generally regarded as solely a maintenance enzyme [54].
Thus, other enzymes are needed to perform de novo DNA
methylation. Dnmt3a and Dnmt3b are widely regarded as the
main enzymes responsible for this role [55, 56]. These methyla-
tion reactions are offset by active and passive demethylation.
Passive demethylation occurs during replication, while active
methylation can involve 10–11 translocation (TET) dioxyge-
nases, which oxidize the methyl groups of cytosine [57]. TET
dioxygenases are thought to function by oxidizing the methyl
groups of cytosine. This process eventually culminates with the
reintroduction of unmethylated cytosine in the DNA molecule
[57]. Thus, it would appear that the steady-state levels of both
site-specific and global DNA methylation patterns are main-
tained by an antagonistic balancing act between those activities
responsible for maintenance/de novo methylation and those re-
actions responsible for passive/active demethylation. Moreover,
methylation fidelity studies suggest that these processes are
subject to inherent stochasticity. For example, Landan et al.
(2012) [58] tracked the in vitro evolution of immortalized fibro-
blasts for >300 generations and found that changes in
population-averaged methylation occur through a stochastic
process. In addition, Shipony et al. (2014) [59] suggest the per-
sistence nature of the somatic methylome is one factor that
makes it increasingly vulnerable to noise with time. This is
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intriguing from the perspective of ageing, as it would appear
that in young somatic cells, site-specific methylation density is
characterized by low-level noise, which maintains average
methylation density. Therefore, the persistent nature of the
methylome and increased stochasticity with time could contrib-
ute to the formation of aberrant DNA methylation patterns,
which are a hallmark of the ageing process in humans.
Computational models of folate metabolism
The models described in the next two sections are summarized
in Tables 1 and 2, respectively. Models of FOCM have tradition-
ally adopted a continuous deterministic approach, with the dy-
namics of the system being represented by ordinary differential
equations (ODEs), which are underpinned by kinetic reactions
[83]. In the main reaction, velocities are assumed to depend on
the concentrations of the reaction substrates (the law of mass
action [84]). Rate laws for more complex reaction laws are in
general described by Michaelis–Menten kinetics [85] for one,
two or three substrates assuming a random-order mechanism.
The following mathematical expressions taken from the recent
model by Salcedo-Sora and Mc Auley (2016) [67] encapsulate the
different Michaelis–Menten-based functional forms as used for
one, two and three substrates in these types of kinetic models,
where V is the velocity of the reaction, Vmax, is the theoretical
maximum velocity of the reaction, S1–S3 are substrates and
km1–km3 are the substrate concentrations at which the reaction
is half maximum velocity.
V ¼ Vmax  ½S
km þ ½S (1)
V ¼ Vmax  ½S1½S2
km1km2 þ km1 ½S2 þ km2 ½S1
(2)
V ¼ Vmax  ½S1½S2½S3
km1km2km3 þ km1 ð½S2 þ ½S3Þ þ km2 ð½S1 þ ½S3Þ þ km3 ð½S1 þ ½S2Þ þ ½S1½S2½S3
(3)
The first mathematical model to adopt this kinetic approach
to represent intracellular folate metabolism was developed in
the 1970s and had a strong pharmacological theme [60]. It was
used to simulate the actions of methotrexate on DNA synthesis.
The next significant computational model of the folate cycle
was developed by Nijhout et al. (2004) [61]. This model is under-
pinned by the enzyme kinetic data that characterize the reac-
tions in Figure 1, and was assembled using the type of
mathematical equations outlined above. As well as being the
first detailed mathematical description of the folate cycle,
model simulations were able to quantitatively reproduce the
intracellular levels of the various folate metabolites, and the
model was able to predict the effect of vitamin B12 deficiency.
Building on this work, Reed et al. (2006) [62] used this model
combined with models of methionine metabolism [63, 64] to in-
vestigate genetic polymorphisms in the folate pathway.
Polymorphisms in MTHFR predicted that a reduction in MTHFR
activity reduces concentrations of SAM and 5-MTHR, and DNA
methylation, while slightly increasing SAH and Hcy concentra-
tions and thymidine or purine synthesis. Decreased folate to-
gether with a simulated vitamin B12 deficiency resulted in
decreased DNA methylation and purine and thymidine synthe-
sis. This model was also used as a template to study the effect
of intracellular folate deficiency and excess. The model
Figure 1. Folate metabolism and its intersection with DNA methylation: Ingested folates are the cofactors for the de novo synthesis of methyl groups. Methyl groups on
5-MTFHF are used to re-methylate homocysteine (Hcy) to methionine, with the aid of vitamin B12 and MS. This reaction regenerates tetrahydrofolate, the metabolically
active form of folate. Methionine is a precursor of SAM, which has a predominant role to play in the majority of biochemical methyl donation events, including that of
DNAmethylation. Dnmt 1 is central to maintaining genomic methylation patterns, while Dnmt 3a and 3b are both involved in de novomethylation reactions. TET diox-
ygenases are actively involved in demethylating cytosine, while CH3 groups are also lost passively. Pink circles indicate methylated CpGs.
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suggested that the enzyme thymidylate synthesis is sensitive to
changes in epithelial intracellular folate and increased signifi-
cantly under conditions of high intracellular folate [65]. This
framework was further extended by Duncan et al. (2013) [66] to
hepatic and plasma folate turnover. It was applied to a popula-
tion of virtual individuals and showed that tissue and plasma
folates are highly correlated, but liver and plasma folates much
less so. Moreover, this model showed that oxidative stress in-
creases the plasma SAM/S-SAM/SAH ratio. The most recent ODE
model of folate metabolism was developed by Salcedo-Sora and
Mc Auley (2016) [67]. Our model is the first computational model
of microbial folate biosynthesis and utilization. Using the
model, we were able to identify specific targets within folateme-
tabolism, which synergize with current antifolates. In addition,
the results from our model support experimental findings that
suggest the folinic acid substrate cycle is an important bio-
chemical mechanism deployed during active cell growth, a key
finding that emphasizes the utility of computational models for
shedding light on this complex system.
Computational models of the DNA
methylation cycle
A variety of approaches have been used to model various as-
pects of DNAmethylation [68–74]. Our focus is the precise repre-
sentation of the DNA methylation cycle. To this end, the DNA
methylation cycle has been modelled explicitly by McGovern
et al. (2012) [77]. The model centred on the activity of DNMTs,
Table 1. A summary of the models of folate metabolism cited in the text
Authors Title Model overview/predictions Computational methods used
Jackson and Harrap (1973) [60] Studies with a mathematical
model of folate metabolism
Included the main reactions
involved in cellular folate me-
tabolism in mouse leukaemia
cells. Used to predict time course
changes in purine and thymidy-
late biosynthesis rates.
A deterministic framework con-
sisting of a system of integrated
equations. Kinetic parameters
were determined from pre-exist-
ing experimental data.
Nijhout et al. (2004) [61] A mathematical model of the fol-
ate cycle: new insights into fol-
ate homeostasis
Folate cycle underpinned by en-
zyme kinetics. Used to explore
the ‘methyl trap hypothesis’, the
effects of methotrexate and sen-
sitivities to variation in enzym-
atic parameters.
A deterministic ODE-based kinetic
model constructed using the as-
sumption that most reactions in
the folate cycle are bimolecular.
Reed et al. (2006) [62] A mathematical model gives in-
sights into nutritional and gen-
etic aspects of folate-mediated
one-carbon metabolism
Model of FOCM. Predictions
included the inverse association
between Hcy and low folate lev-
els, DNAmethylation reaction
rate is relatively insensitive to
changes in folate pool size, fol-
ate concentrations become high,
enzyme velocities diminish, mu-
tations in MTHFR reduces SAM.
Deterministic ODE model created
by combining the model by
Nijhout et al. (2004) and models
of methionine metabolism
[63, 64].
Neuhouser et al. (2011) [65] Mathematical modelling predicts
the effect of folate deficiency
and excess on cancer-related
biomarkers
FOCMmodel used by this group.
Used to predict: the effect of a
broad range of intracellular folate
concentrations simulating vari-
ation in folate status on mechan-
isms relevant to carcinogenesis.
Deterministic model based on [62].
Duncan et al. (2013) [66] A Population Model of Folate-
Mediated One-Carbon
Metabolism [66]
Compartmental body model folate
metabolism.
Showed tissue and plasma folate is
highly correlated, but liver and
plasma folate much less so.
Oxidative stress increases the
plasma SAM/SAH ratio.
Models from [61, 62] were incorpo-
rated into liver and plasma
compartment.
Coupled set of ODEs.
Random number used to generate
a virtual population of 10 000 in-
dividuals each with different fol-
ate metabolism.
Model constructed using Matlab.
Salcedo-Sora and Mc
Auley (2016) [67]
A mathematical model of micro-
bial folate biosynthesis and util-
ization: implications for
antifolate development.
First model to be assembled of fol-
ate biosynthesis and utilization.
The model suggested a particular
small set of folate intermediates
are specific targets that could
complement current antifolates,
and the model substantiates the
case for a substrate cycle in the
folinic acid biosynthesis
reaction.
Deterministic ODE model.
Folate pathway informed by the
KEGG database (http://www.gen
ome.jp/kegg/) and kinetic param-
eters were compiled from the en-
zyme database BRENDA (http://
www.brenda-enzymes.org/)
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and partial differential equations were used to represent
methylation reactions. It was used as a predictive tool for
haematological malignancies. The model was able to predict
the relative abundances of unmethylated, hemimethylated,
fully methylated and hydroxymethylated CpG dyads in the
DNA of cells with fully functional methylation and TET en-
zymes. In addition to this deterministic framework, stochastic
models of the methylation cycle have also been used to study
the methylation cycle. The goal has been to derive models that
account for the noise associated with maintaining DNA methy-
lation levels. For example, a reduced probabilistic mathematical
representation of methylation dynamics (known as the stand-
ard/classical model) has been proposed by Pfeifer et al. (1990)
[86], and further used by Riggs and Xiong (2004) [78]. This model
is presented in Equations (4–7).
dM
dt
¼ Em Mþ Ed  U (4)
dU
dt
¼ ð1 EdÞ  Uþ ð1 EmÞ M (5)
M^ ¼ M
Total
¼ MðMþ UÞ (6)
M^ ¼ Edð1þ Ed EmÞ (7)
To briefly explain the ODEs in Equations (4) and (5), and
Equations (6) and (7), M is a CpG site, U is its unmethylated
state, Ed is the efficiency of de novo methylation, Em is the effi-
ciency of maintenance methylation, M is the number of methy-
lated sites, M^ is the fraction of methylation, while Equation (7)
represents the steady-state solution to ODEs 4 and 5 when dM^/
dt ¼ 0. This model is underpinned by the idea that site-specific
methylation levels are underscored by a stochastic process,
where de novo and maintenance methylation activity are cen-
tral. Recently, Jeltsch and Jurkowska (2014) [79] provided an
intriguing theoretical extension to this concept. Jeltsch and
Jurkowska propose a stochastic model, which also includes the
rate of cell division together with passive and active demethyla-
tion; Equation (8). him is the change in the fraction of methyla-
tion at any CpG site (i). This is determined by the difference
between the rate of de novo DNA methylation (rimet) and rates of
loss of methylation by replication and active demethylation
(ridemeth) at this site. D is the rate of cell division and f
i
main is the ef-
ficiency of maintenance methylation at site i.
dhim
dt
¼ rimet  1 him
 
 1
2
Dð1 f imainÞ þ ridemeth
 
 him (8)
According to the authors, Equation (8) has the significant ad-
vantage over its predecessor, as it includes the possibility of
proofreading/repair mechanisms because of the incorporation
of negative feedback. This level of regulation is attained be-
cause an increase in methylation causes a reduction in the first
term of Equation (8) with a subsequent increase in the second
term. Consequently, the methylation rate drops and demethy-
lation increases, resulting in a stable steady-state methylation
level at each site. To our knowledge, this theoretical framework
has yet to be applied to experimental data or simulated dynam-
ically. A stochastic mathematical framework also inspired
Haerter et al. (2014) [80] to create a computational model of this
system. Their model differs from the classical/standard model,
as it included dynamic collaboration between CpGs. MoreT
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recently, Olariu et al. (2016) [82] built on the work of Haerter et al.
(2014) to model the regulation of transcription and DNA
methylation.
Rationale for computationally integrating
FOCM and the DNAmethylation cycle
Computational models of FOCM are not fully integrated with
the DNA methylation cycle. Rather, as outlined, they have been
restricted to the cycle itself or its involvement with DNA syn-
thesis and have tended not to include the DNA methylation
cycle. Some have attempted to account for DNA methylation,
but no model to our knowledge has explicitly integrated both
systems in a meaningful way. We propose computationally
integrating FOCM and the methylation cycle. Our biological ra-
tionale is unpinned by the knowledge that perturbations in the
folate cycle are strongly coupled with aberrant DNA methyla-
tion. This is evidenced by the association between low folate
status, global DNA hypomethylation and increased cancer risk
[87]. In addition, genetic polymorphisms, most notably in the
MTHFR gene, which codes for MTHFR, an enzyme that catalyses
the conversion of 5, 10-methylenetetrahydrofolate to 5-MTFHF
(Figure 1), are associated with gene promoter hypermethylation
[88]. Moreover, MS A2756G (MTR A2756G) is a common
polymorphism in the gene encoding MS. This enzyme catalyses
the regeneration of methionine from Hcy, and disruptions to its
enzymatic capabilities also emphasize the close link between
folate metabolism and disruptions to DNA methylation. For in-
stance, Weiner and colleagues (2014) [88] found that individuals
homozygous for this mutant allele showed higher leukocyte
genomic DNA methylation levels than individuals possessing
the wild-type genotype (MTR 2756AA). It makes mechanistic
sense that perturbations of this nature to FOCM have an impact
on DNA methylation, as 5-MTFHF is a cosubstrate for Hcy re-
methylation to methionine, while MS modulates the dynamics
of this reaction, and perturbations to this enzyme result in a
rise in plasma Hcy [89], which is associated with CVD [90].
Intriguingly, a rise in plasma Hcy has also been associated with
gene promoter hypermethylation [91–94] and global hypome-
thylation [95–97] of human DNA.
In addition to perturbations because of genetic mutations, it
is important to recognize that FOCM compartmentalization
could have implications for DNA methylation status, as com-
partmentalization of FOCM has a role to play in regulating the
distribution of one-carbon units within the cell. The partitioning
of one-carbon units between nucleotide synthesis and Hcy re-
methylation is the focal point of this process, where methylene-
tetrahydrofolate (MTHF) is at the centre of a metabolic
(a) (b)
Figure 2. (a) Stochastic contributions to CpG island methylation: Methylation density is affected by intrinsic and extrinsic noise. On the one hand, noise is necessary
and evolution has finely tuned this system so that stochasticity helps to maintain average methylation density in young cells. However, the ageing process results in
gradual increase in stochasticity, which eventually culminates with promoter hypermethylation. During aging, gene promoter methylation has been identified within
a wide variety of genes involved in health span/ageing (refer to Table 4 for full function and description). Included also are the equations, which define intrinsic and ex-
trinsic noise, which are discussed in the main text (mathematical equations based on framework introduced by Elowitz colleagues (2002) [122]). (b) presents a summary
of the combined model represented by a set of indicative reactions which could be modelled using propensity functions. Abbreviations: F, folate; THF, tetrahydrofolate;
5MTHF, 5-methyltetrahyrofolate; 510MTHF, 5,10-methylenetetrahydrofolate; Met, methionine; SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine; Hcy,
homocysteine; DHF, dihydrofolate; 10Form, 10-formyl THF.
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competition [98, 99]. On the one hand, MTHF is used as a cofac-
tor during nucleotide synthesis to facilitate the conversion of
dUMP to dTMP by thymidylate synthase (TYMS). However,
MTHF can also be reduced and is then fully committed to the
re-methylation of Hcy. The separation of FOCM into distinct cel-
lular compartments is the determining factor, which regulates
the competition between TYMS and MTHFR for MTHF [100].
This regulation requires the trifunctional, enzyme methylenete-
trahydrofolate dehydrogenase (MTHFD1), whose activity de-
pends on its cellular location [100]. The interdependence of this
enzyme’s activity to its location and its involvement in regulat-
ing the competition between MTHFR and TYMS are evident
when intracellular folate levels are deficient, as insufficient lev-
els of folate cause an accumulation of MTHFD1 in the nucleus,
when compared with its cytosolic counterpart [101]. The nuclear
build-up of MTHFD1 emphasizes FOCM will sacrifice Hcy re-
methylation in favour of nucleotide synthesis and underscores
the regulatory role compartmentalization plays in one-carbon
metabolism. Intriguingly, this aspect of FOCM could have wider
implications, as recently it has been shown that changes to
MTHFD1 can affect the regulation of DNA methylation. Groth
et al. (2016) [102] identified a mutant (mthfd1-1) in Arabidopsis
thaliana, which carried a mutation in cytoplasmic MTHFD1. This
mutant suffered from accumulation of Hcy and SAM, coupled
with extensive genome-wide hypomethylation. Compartmental
regulation of FOCM is also highlighted by cytosine serine
hydroxymethyltransferase (SHMT). SHMT1 catalyses the con-
version of tetrahydrofolate to 5, 10-methylenetetrahydrofolate
and also converts serine to glycine. It has been found that cyto-
sine SHMT1 preferentially supplies one-carbon units for thymi-
dylate synthesis [99, 103]. Mechanistically, it has been found
that this preference is mediated by small ubiquitin-like modifier
(SUMO) modification. This alteration enables the translocation
of SHMT to the nucleus and also modifies its catalytic capabil-
ities [104]. Sumoylation could also be crucial to both DNA
methylation and demethylation, as SUMO-1 modification of
DNMT1 had been shown to significantly enhance DNMT1 activ-
ity [105]. It is also possible that sumoylation is capable of modu-
lating the activity of Dnmt3a and Dnmt3b [106]. This level of
crossover between FOCM and DNA methylation consolidates
the view that disruptions to FOCM impact the dynamics of DNA
methylation/demethylation events. However, the full extent of
this relationship remains to be elucidated, hence the growing
need for an integrated computational model to explore the
complex interactions of these systems.
Theoretical frameworks and obstacles to
creating a combined model
To develop a combined model, several theoretical approaches
could be adopted. FOCM could be retained as a set of kinetic-
based ODEs, as is the case in the majority of models of this na-
ture. It would then be straightforward to add the methylation
cycle as ODEs also and to define the combined system as a
coupled set of ODEs. Despite the obvious computational advan-
tages of this simplification, these benefits are offset by several
factors. First, to assemble this deterministic model, the ODEs
need to be informed by kinetic data, which account for the be-
haviour of the methylation enzymes. This is not a straightfor-
ward task, as parameter uncertainty is a significant issue in the
field of computational systems biology. As outlined, kinetic-
based models of folate metabolism tend to have rate laws where
the velocity of a reaction assumes mass action kinetics or is
based on an enzyme kinetic law (e.g. Michaelis–Menten kin-
etics). Unfortunately, kinetic parameters can vary significantly
depending on the circumstances in which their kinetics were
quantified and the biological source, with the possibility of
model parameters varying by several orders of magnitude de-
pending on the particular source [107]. Therefore, it is extremely
unlikely that a mathematical model can be assembled from one
biological source. This is highlighted by our recent model of mi-
crobial folate metabolism, where the parameters were derived
from a number of sources [67]. It is also a feature of the mam-
malian computational models, which have previously relied on
data from rat, mice and human studies [61]. Despite such pit-
falls, there is no alternative to this approach of determining
model parameters. To this end, a number of databases now
exist that archive kinetic data for the purpose of assembling
computational models [108, 109]. We used these databases to
identify a series of indicative kinetic parameters for the model
outlined diagrammatically in Figure 1 and are summarized in
Table 3. The identification of these parameters serves to em-
phasize that it is possible to assemble a combined kinetic model
of folate metabolism and the DNA methylation cycle based on
human data; however, the data are limited. Moreover, we were
able to identify kinetic parameters for Dnmt1 and Dnmt3A [119,
120]; however, kinetic information for the TET demethylation
enzymes could not be identified.
Although, as outlined above, it is clearly possible to assem-
ble a combined deterministic kinetic model, given experimental
evidence indicates that DNA methylation events are under-
scored by stochasticity; a kinetic-based deterministic approach
is not the correct way to model this aspect of the system. A
more accurate way is to incorporate noise into the model. The
standard way of representing noise within biological cells is to
describe it mathematically by a master equation or to simulate
molecule fluctuations by using a stochastic simulation algo-
rithm (SSA), such as the Gillespie algorithm or one of its deriva-
tives [81, 121]. Routinely embedded within the idea of
intracellular noise is the concept of intrinsic versus extrinsic
noise, as developed experimentally by Elowitz and colleagues
(2002) [122]. Within this context, intrinsic noise refers to the
variability inherent to the system under consideration, while
fluctuations in those factors classified as external to the system
of interest are responsible for extrinsic noise (Figure 2).
Specifically, this mathematical approach has been ubiquitously
applied to the study of cell-to-cell variability in gene expression
levels within isogenic cell populations [123–126].
Applying the above logic to our indicative model, it can be
argued that the reactions of the methylation cycle are respon-
sible for generating intrinsic noise, e.g. the inherent statistical
mechanical fluctuations in the binding and diffusion dynamics
of the molecules involved in maintaining methylation levels
within a CpG island/gene body. Conversely, DNA methylation/
the epigenetic state of the cell is considered to be a component
of extrinsic noise when variations in gene expression are mod-
elled in this way. We suggest extrinsic noise in our integrated
model arises because of biochemical fluctuations originating
from the folate cycle and other cell parameters, particularly
those related to ageing (Figure 2). Including biochemical noise
arising from FOCM is crucial especially if one considers that
site-specific (e.g. gene promoter) DNA methylation events inter-
act with FOCM within a microscopic rather than macroscopic
environment. This microenvironment is characterized by low
molecular populations, which react at discrete time-points, via
random collisions between individual molecules. The advan-
tage of this framework is its simplicity, as a complex biological
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network is reduced to a much simpler abstraction. A drawback
of this approach is that it reduces the methylation cycle and
FOCM to two variables within a phenomenological model,
which lumps all sources of extrinsic noise together. Moreover,
as we are concerned with the complexities of the reactions of
folate metabolism and how changes to these impact DNA
methylation events, it is challenging to separate this source of
noise from other extrinsic events, e.g. the impact of the cell
cycle. A further challenge associated with this proposal is that
to characterize the intrinsic noise for a given gene promoter, it
would be necessary to experimentally characterize promoter-
specific cell-to-cell methylation variability in young disease-
free cells and how this relates to protein expression levels. For
instance, microscopy or flow cytometry is routinely used to
quantify protein expression variability in reporter genes
embedded in homogenous cell populations [136, 137]. Protein
count distributions then provide an overview of cell-to-cell
fluctuations in gene expression. The stochastic profile can
then be characterized as the squared coefficient of variation of
the fluorescence levels [138], the coefficient of variation [122]
or the Fano factor [139]. Therefore, it would be necessary to de-
velop experimental methods, which are capable of determin-
ing the exact nature of the stochasticity of the DNA
methylation process. However, given that DNA methylation
levels are quantified in a totally different manner to protein
fluctuations, it is could be challenging to define/characterize
its stochastic signature in a precise way experimentally. Next-
generation sequencing techniques could help to alleviate this
problem. These techniques enable the determination of the
methylation status at each cytosine for a specific segment of
the genome. An eloquent example of this approach is the work
of Hansen et al. (2011) [140], who showed stochastic methyla-
tion of cancer-specific DNA-methylated regions. This was able
to distinguish cancer from normal tissue. More recently,
Cheow et al. (2016) [141] developed a method to genotype indi-
vidual cells while concurrently probing gene expression and
DNA methylation levels at multiple loci. Such methods could
help identify an individual stochastic signature for a particular
gene promoter/gene body, which would help inform the math-
ematics underpinning future computational models. An alter-
native to the reduced stochastic model approach would be to
explicitly represent each deterministic kinetic reaction within
FOCM and the DNA methylation cycle as stochastic propensity
functions and to simulate the integrated model with a SSA
[100], as has been done with other complex biochemical sys-
tems [142]. In Figure 2B, we have created a list of reactions,
which could be represented as propensity functions, where C1–
C7 are indicative of stochastic rate constants. This is not un-
realistic, as mathematical approaches have been developed
previously for converting deterministic systems biology mod-
els into stochastic models [143–145]. However, regardless of
the approach, it is our opinion that future computational mod-
els should combine these two systems together. Moreover, it is
imperative that any combined model accounts for the bio-
chemical and molecular variability, which is inherent to both
systems. This will improve our overall understanding of how
those gene promoters, which appear to be susceptible to
hypermethylation, interact with both folate metabolism and
the ageing process.
Conclusions
Folate metabolism and the DNA methylation cycle are inexor-
ably entwined, as the folate cycle provides the methyl groups
used in DNAmethylation reactions. Experimental evidence sug-
gests the dynamics of the folate cycle and the DNA methylation
cycle are subject to inherent stochasticity. Investigating this be-
haviour is challenging; however, computational modelling
offers an ideal framework for exploring the interactions be-
tween these two systems. In this review, we proposed building
a computational model of folate metabolism coupled with the
reactions of the methylation cycle. This model would help to
further explore the dynamics of this relationship and could be
used to investigate how disruptions to these processes result in
aberrant DNA methylation status, specifically gene promoter
hypermethylation.
Key Points
• Folate metabolism has a vital role to play in health
and possibly intrinsic ageing.
• Folates supply methyl groups for DNA methylation re-
actions, which are central to gene regulation.
• Dynamic computational models have been success-
fully used to study the complexities of folate metabol-
ism and the DNA methylation cycle, respectively, but
no model has fully coupled both systems.
• To combine both systems computationally, it is im-
portant to account for the inherent stochasticity,
which influences the dynamics of both systems.
• Incorporating inherent biochemical and molecular
variability will provide an improved understanding of
how perturbations to these systems impact the onset
of disease and will help to further elucidate the bidir-
ectional relationship between ageing and DNA
methylation.
Appendix
Deterministic model: A model that assumes variability does not
impact the system of interest. The model will produce the same
output given the same initial conditions and parameters.
Extrinsic noise: Fluctuations in the factors external to the bio-
logical system of interest, e.g. biochemical fluctuations in the
folate pathway and its impact on gene expression.
Gillespie algorithm: An algorithm used to generate stochastic
models of reaction networks.
Intrinsic noise: Noise associated with a biological system of
interest, e.g. in the case of this review, site-specific DNA
methylation.
Stochastic model: A model grounded in probability theory,
which is used to represent the variability inherent in biological
processes. In this review, we suggest FOCM is combined with
the DNA methylation cycle into a single stochastic model to
capture the inherent variability in body systems.
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